Revenue increased 14.9%
Revenue changed +14.9% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +14.9% from the comparable as-filed period.
Current ratio changed -20.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -13.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Inventory / revenue changed -465 basis points from the comparable as-filed period.
Free-cash-flow proxy changed +13.8% from the comparable as-filed period.
Capital expenditure changed -66.8% from the comparable as-filed period.
Gross margin changed -143 basis points from the comparable as-filed period.
R&D / revenue changed -337 basis points from the comparable as-filed period.
Operating cash-flow margin changed -715 basis points from the comparable as-filed period.
Operating cash flow / net income changed -42.5% from the comparable as-filed period.
Cost of revenue changed +21.4% from the comparable as-filed period.
Inventory changed +11.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Receivables / revenue changed +243 basis points from the comparable as-filed period.
Current liabilities changed +9.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +15.8% from the comparable as-filed period.
Operating cash flow changed +3.1% from the comparable as-filed period.
Gross profit changed +12.7% from the comparable as-filed period.
Total assets changed -3.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
SBC / revenue changed -65 basis points from the comparable as-filed period.
Free-cash-flow margin changed -61 basis points from the comparable as-filed period.
Research & development changed +0.0% from the comparable as-filed period.
Stock-based compensation changed -1.2% from the comparable as-filed period.
Revenue changed -11.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Capital expenditure changed -68.0% from the comparable as-filed period.
Gross margin changed -136 basis points from the comparable as-filed period.
Inventory changed +19.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -47.4% from the comparable as-filed period.
SBC / revenue changed -221 basis points from the comparable as-filed period.
Operating cash flow / net income changed -34.5% from the comparable as-filed period.
Free-cash-flow margin changed -843 basis points from the comparable as-filed period.
Operating cash-flow margin changed -1381 basis points from the comparable as-filed period.
Trade receivables changed -14.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Gross profit changed -13.0% from the comparable as-filed period.
Receivables / revenue changed -265 basis points from the comparable as-filed period.
Total assets changed -2.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current liabilities changed -11.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Selling, general & administrative changed -9.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -6.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed -181 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed -6.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cost of revenue changed -6.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +182 basis points from the comparable as-filed period.
Research & development changed -3.8% from the comparable as-filed period.
Current ratio changed +5.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.